Literature DB >> 33832022

[Interpretation of WHO consolidated guidelines on tuberculosis module 4: drug resistant tuberculosis treatment].

L J Zhang, Y H Liu, J T Gao, Z Chen, L Li.   

Abstract

Entities:  

Year:  2021        PMID： 33832022     DOI： 10.3760/cma.j.cn112147-20200709-00786

Source DB:  PubMed          Journal:  Zhonghua Jie He He Hu Xi Za Zhi        ISSN： 1001-0939


× No keyword cloud information.
  3 in total

1.  Tuberculosis related disability: a systematic review and meta-analysis.

Authors:  Kefyalew Addis Alene; Kinley Wangdi; Samantha Colquhoun; Kudakwashe Chani; Tauhid Islam; Kalpeshsinh Rahevar; Fukushi Morishita; Anthony Byrne; Justin Clark; Kerri Viney
Journal:  BMC Med       Date:  2021-09-09       Impact factor: 8.775

2.  Low prevalence of isoniazid preventive therapy uptake among HIV-infected patients attending tertiary health facility in Lagos, Southwest Nigeria.

Authors:  Abdulwasiu Adeniyi Busari; Kazeem Adeola Oshikoya; Ifedolapo Adesola Adejumo; Olamide Ayinke Olanrewaju; Sikiru Olatunji Usman; Wasiu Adedeji Badru; Ibrahim Adekunle Oreagba; Sunday Oluwafemi Olayemi
Journal:  Pan Afr Med J       Date:  2021-06-13

3.  High success and low recurrence with shorter treatment regimen for multidrug-resistant TB in Nepal.

Authors:  S Koirala; N P Shah; P Pyakurel; M Khanal; S K Rajbhandari; T Pun; B Shrestha; B Maharjan; S Karki; S Koirala; K B Tamang; A Roggi; A M V Kumar; N Ortuño-Gutiérrez
Journal:  Public Health Action       Date:  2021-11-01
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.